Klea HoldingVMDGF 37 Market Cap is $64.06 Mil as of Jul. 03, 2026. GuruFocus rates VMDGF with a GF Score™ of 37/100 and a GF Value™ of $0.37. The stock has 2 warning signs investors should review. Among 218 Medical Diagnostics & Research companies, Klea Holding ranks better than 51.83% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Klea Holding's share price for the quarter that ended in Dec. 2025 was $0.45. Klea Holding's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 306.06 Mil. Therefore, Klea Holding's market cap for the quarter that ended in Dec. 2025 was $137.73 Mil.
Klea Holding's quarterly market cap
increased
from Dec. 2024 ($138.14 Mil) to Jun. 2025 ($138.18 Mil) but then
declined
from Jun. 2025 ($138.18 Mil) to Dec. 2025 ($137.73 Mil).
Klea Holding's annual market cap
increased
from Dec. 2023 ($102.96 Mil) to Dec. 2024 ($138.14 Mil) but then
declined
from Dec. 2024 ($138.14 Mil) to Dec. 2025 ($137.73 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Klea Holding's Enterprise Value for Today is $64.07 Mil.
Klea Holding (OTCPK:VMDGF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Klea Holding Market Cap Related Terms
Klea Holding Market Cap Historical Data
* Premium members only.
The historical data trend for Klea Holding's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Klea Holding's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Klea Holding Market Cap vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Klea Holding's Market Cap distribution charts can be found below:
* The bar in red indicates where Klea Holding's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Klea Holding's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Klea Holding (VMDGF) has a Market Cap of $64.06 Mil as of Jul. 03, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Klea Holding and its competitors. According to the industry distribution chart, Klea Holding ranks #105 out of 218 companies in the Medical Diagnostics & Research industry, placing it in the top 48.2%.
Is Klea Holding's Market Cap too high?
Klea Holding's current Market Cap is $64.06 Mil. The Medical Diagnostics & Research industry median Market Cap is 58.14. Klea Holding's value of $64.06 Mil is 10.2% above this industry median. Based on the distribution chart, Klea Holding ranks #105 out of 218 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Klea Holding has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Klea Holding's Market Cap compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Klea Holding ranks #105 out of 218 companies for Market Cap. This puts Klea Holding in the upper half of its industry. The industry median Market Cap is 58.14. Klea Holding's value of $64.06 Mil is 10.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Diagnostics & Research company?
The median Market Cap among Medical Diagnostics & Research companies is 58.14, based on 218 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Klea Holding's current Market Cap of $64.06 Mil is 10.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Klea Holding and its competitors. For the Medical Diagnostics & Research industry, the median Market Cap is 58.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Klea Holding's current Market Cap is $64.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Klea Holding stock overvalued right now?
Klea Holding (VMDGF) has a current Market Cap of $64.06 Mil. The stock's GF Value™ is $0.37, compared to a current price of $0.20 — trading 45.9% below its estimated fair value. The current Market Cap is $64.06 Mil and 10.2% above the Medical Diagnostics & Research industry median of 58.14. Klea Holding's overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Klea Holding (VMDGF), the current Market Cap is $64.06 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Klea Holding (VMDGF) Overvalued in 2026?
Based on GuruFocus' analysis, Klea Holding stock appears to be undervalued.
The current stock price of $0.20 is trading 45.9% below its estimated GF Value™ of $0.37.
Key valuation signals for VMDGF:
Market Cap: $64.06 Mil
GF Value™: $0.37 vs. price of $0.20 (45.9% below fair value)
Industry Position: 10.2% above the Medical Diagnostics & Research median (#105 of 218)
No single metric tells the full story. See the VMDGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Klea Holding focused on the acquisition, development and digitalization of companies in multiple sectors. Its development of Smart Salem, the first network of digital medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the Emirates United Arabs, or its Smart Health joint venture developed in Saudi Arabia.
37GF Score
Get the complete analysis for VMDGF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VMDGF has been successfully added to your 
